Gavi andMastercard join forces to ensure vaccines for children
December 18, 2018

MASTERCARD and Gavi, the Vaccine Alliance, announced recently at a high-level conference for Gavi’s 2018 mid-term review, a new transformative partnership to ensure more children from the poorest countries are able to benefit from life-saving immunization programs.

Although major progress has been made to increase immunization rates, one in five children in Gavi-supported countries are still not reached with basic lifesaving vaccines. In many developing"...

Celgene Corporation Announces Celgene Cancer Care Links™ Program Grant Recipients
December 17, 2018

(AETOS Wire) -- Celgene Corporation (NASDAQ:CELG) today announced ten programs selected for funding under its Celgene Cancer Care Links™ program, an initiative designed to support cancer healthcare capacity building in resource-constrained countries around the world.

The programs selected are expected to support established institutions partnering"...

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD
December 17, 2018

(AETOS Wire) -- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català......

Exciting Prizes Await the Winners of This Year’s Spinneys Dubai 92 Cycle Challenge
December 15, 2018

The Spinneys Dubai 92 Cycle Challenge will take place this weekend,with Junior Ridesfor young cyclists from 5 pm to 9 pmon December 13thanda 92km ride between 6 am and 11 am on December 14th. The Cycle Challenge’s Official Rehabilitation and Performance Partner isnanoM, a state-of-the-art sports and human performance facility that provides amateur and professional athletes with comprehensive health and fitness analyses.

Thursday’s"...

Ebola: How Many Must Die Before WHO Acts? asks AHF
December 14, 2018

(AETOS Wire)-- With the world’s second worst Ebola outbreak in history recently spreading to a major city in the Democratic Republic of the Congo, the World Health Organization (WHO) and Merck must do more to ensure all options are on the table to fight the virus, including ensuring vaccines are available to all who need them. Although there have been marked improvements compared to the 2014 outbreak response in West Africa, a more ambitious effort is needed now in the Congo. The WHO has yet to declare the crisis an international emergency, even though it meets its own criteria for what constitutes one. Additionally, Merck Pharmaceuticals only has 300,000 doses of its proven Ebola vaccine on hand—far too little than what is needed now that the virus has reached Butembo, a sprawling urban......

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer
December 14, 2018

(AETOS Wire)-- Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow"...

As Interest in Sports Medicine Increases in the UAE, Cutting Edge Facility Welcomes Consultant Orthopaedic Surgeon
December 12, 2018

In line with the growing emphasis on sports medicine in the United Arab Emirates, Dr. Herve Ouanezar, MD has joined the team at Dubai-based nanoM, a state-of-the-art performance and health assessment facility catering to professional athletes.

nanoM’s newest Consultant Orthopaedic Surgeon, Dr. Ouanezar graduated at the top of his class from Claude Bernard University Medical School in"...

UAE-based Emirates Rehabilitation & Homecare Earns Another Three-Year CARF Accreditation
December 11, 2018

CARF International announced that Emirates Rehabilitation & Homecare Services (ERHC) has been accredited for three years for its Home and Community-Based Rehabilitation program (Adults, Children & Adolescents). This accreditation decision represents the highest level of accreditation that can be given to an organisation and shows ERHC’s substantial conformance to the CARF standards. With this latest accreditation, Emirates Rehabilitation and Homecare"...

Leading Emirates health care, education investor eyes Saudi Arabia
December 10, 2018

LONDON: Since launching Foundation Holdings in 2016, Abhishek Sharma has scoured the GCC and India for investment opportunities.

Now, the prominent UAE health care and education investor is closing in on targets in Saudi Arabia.

“We are eyeing two interesting investments in KSA at the moment. Saudi Arabia"...

Fakih IVF Fertility Center Expands Its Footprint in the UAE with the Launch of a New Centre in Al Ain
December 9, 2018

Expanding its services and operations in the UAE, Fakih IVF Fertility Center – the Middle East’s leading fertility services provider launched a new facility in Al Ain on December 5, 2018.

The new clinic, Fakih IVF’s fourth in the GCC region, is part of a vision to be the worldwide leader in fertility treatment. The new centre was inaugurated by Prasanth Manghat, CEO and"...